Enveric Biosciences, Inc.
ENVB· Nasdaq
Filed May 3, 2012 · 10-Q · 33 days after period end · 0001477932-12-001373
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$4.05K | -$11.08K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 3, 2012 · 33 d after period end